• A breath of unique innovation

    Pioneering inhalation products and extensive know-how in drug formulation

    Get to know us!
  • A formulation to match the device

    The right chemistry in the right inhaler takes you to the market faster

    Take me there!
  • Capitalize on a pool of knowledge

    Get from bench to bedside – faster and at lower risk

    Discover how
  • For those who need it the most

    ICOone™ – inhale vaccine instead of injecting. Safe method that eliminates all cold-chain storage.

    Learn how
  • A breath of unique innovation »
  • A formulation to match the device »
  • Capitalize on a pool of knowledge »
  • For those who need it the most »

News

  • Dr Orest Lastow is lecturing at Dry Powder Inhalers Annual Conference London 20-21 June 2018

    2018-05-25
    The second generation of DPIs have become either established on the market or are a significant way along the approval ... Read more
  • Interview with Dr Orest Lastow May 2018 (only in Swedish)

    2018-05-24
    På Erik Penser Banks bolagsdag den 23 maj fick Finwire.tv möjligheten att intervjua Dr Orest Lastow, VD på Iconovo. S... Read more
  • Market analys of Iconovo by Erik Penser Bank (only in Swedish)

    2018-05-21
    Iconovo utvecklar inhalationsprodukter primärt för behandling av astma och kroniskt obstruktiva lungsjukdomar (KOL). G... Read more
  • Dr Orest Lastow lecturing at Shenyang Pharmaceutical University

    2018-05-14
    The CEO of Iconovo, Dr. Orest Lastow, was invited to Shenyang Pharmaceutical University to give one-day seminar on inhal... Read more
  • Mechanical engineer for development of medicinal inhalers at Medicon Village in Lund

    2018-04-24
    Iconovo is hiring a mechanical engineer to further strengthen the full development cycle of medicinal inhalers. You alre... Read more
  • Iconovo is attending RDD April 22-26, 2018

    2018-04-19
    Iconovo is attending RDD (Respiratory Drug Delivery) April 22-26, 2018. Come and visit us at table 63 and we will tell y... Read more
  • NOTICE OF ANNUAL GENERAL MEETING IN ICONOVO AB

    2018-04-17
    The shareholders of Iconovo AB, 556938-0156, are invited to the Annual General Meeting on Wednesday 16 May 2018 at 17.3... Read more
  • Iconovo to Nasdaq first North

    2018-04-10
    Nasdaq welcomes Iconovo to First North.... Read more
  • Erbjudandet i Iconovo övertecknat inför börsnotering på First North (only in Swedish)

    2018-03-26
    Erbjudandet i Iconovo övertecknat inför börsnotering på First North. Pressrelease_Iconovo 2018-03-26... Read more
  • Interview with Dr. Orest Lastow, CEO Iconovo (only in Swedish)

    2018-03-21
    Nyhetsbyrån Direkt intervjuar Dr. Orest Lastow, se intervjun här.... Read more
Older news

A unique platform of inhalation devices

Iconovo offers a full range of innovative, ready-to-use inhalation devices for dry powder inhalation (DPI). Our solution consists of a combination of inhaler and the exactly right formulation to match the device and the drug to be delivered. Each solution is based on our proprietary platform but will be customized and adapted to your unique requirements. We can also provide performance testing, full documentation and a complete supply chain. Our long and unique experience and capability in the development of inhalation devices and formulations enable you to get your product to the market in a fast and efficient way.